<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:department>Chemistry</gtr:department><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/D1774113-D5D2-4B7C-A412-66A90FE4B96F"><gtr:id>D1774113-D5D2-4B7C-A412-66A90FE4B96F</gtr:id><gtr:name>University of Cambridge</gtr:name><gtr:address><gtr:line1>Lensfield Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 1EW</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78778E97-5A2E-40A6-A88F-137A343A3530"><gtr:id>78778E97-5A2E-40A6-A88F-137A343A3530</gtr:id><gtr:name>University of Toronto</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/E3241676-C5F4-44EA-938D-E6C6EF8C4E50"><gtr:id>E3241676-C5F4-44EA-938D-E6C6EF8C4E50</gtr:id><gtr:name>Unilever R&amp;D Vlaardingen B.V.</gtr:name><gtr:address><gtr:line1>Unilever Research</gtr:line1><gtr:line2>Laboratory</gtr:line2><gtr:line3>Olivier Van Noortlaan 120</gtr:line3><gtr:postCode>NL-3133 AT</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/4E55B119-02E7-43F3-9B39-DD48A6511372"><gtr:id>4E55B119-02E7-43F3-9B39-DD48A6511372</gtr:id><gtr:name>Addenbrooke's Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/82F274CB-C3AA-445B-9714-3CF56785F38E"><gtr:id>82F274CB-C3AA-445B-9714-3CF56785F38E</gtr:id><gtr:name>Johns Hopkins University</gtr:name><gtr:address><gtr:line1>3400 North Charles Street</gtr:line1><gtr:line4>Baltimore</gtr:line4><gtr:line5>MD 21218</gtr:line5><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/6D374D11-E09E-4483-9427-B7805F38B2FC"><gtr:id>6D374D11-E09E-4483-9427-B7805F38B2FC</gtr:id><gtr:firstName>Robert</gtr:firstName><gtr:otherNames>Charles</gtr:otherNames><gtr:surname>Glen</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0401505"><gtr:id>EED8AD44-B6DD-4CFB-A8D2-608CD5662F02</gtr:id><gtr:title>Statistical complexity measure as a diagnosis tool for cardiac rhythms</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0401505</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-10-16</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2005-10-17</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>42834</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Unilever</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Analysis of heart health data</gtr:description><gtr:id>E13145DF-6E72-4AE5-A056-F1CD9F441F49</gtr:id><gtr:impact>Six Months Funding from Unilever for data analysis on the work done to date in collaboration with Dr. Mike Gatt in Unilever Colworth and Prof. Rob Nolan in Toronto. This allowed additional use of the statistical complexity measures we have developed.</gtr:impact><gtr:outcomeId>hJZgLhgKVhw-2</gtr:outcomeId><gtr:partnerContribution>exchange of data</gtr:partnerContribution><gtr:piContribution>The project also stimulated additional research (which is ongoing) with Unilever on analysis of heart health data in collaboratidn with Prof. Robert Nolan from the University of Torronto in Canada.</gtr:piContribution><gtr:sector>Private</gtr:sector></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Johns Hopkins University</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>School of Medicine Johns Hopkins</gtr:department><gtr:description>use of software in other institutions</gtr:description><gtr:id>A0CD7104-3A4F-4D44-8CB8-F56DE0551B14</gtr:id><gtr:impact>This is being investigated to assist diagnosis</gtr:impact><gtr:outcomeId>NhXSHJXbhFL-1</gtr:outcomeId><gtr:partnerContribution>They use our software
http://www.cvrgrid.org/cvrg-tool-demonstrations
in their cardiovascular research grid</gtr:partnerContribution><gtr:piContribution>Our software for QT detection in cardiac ECG's has been used to assist diagnosis</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Addenbrooke's Hospital</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>Further collaborations on cardiovascular disease</gtr:description><gtr:id>9B30A158-09E1-403C-B2DB-D79B209ABFA2</gtr:id><gtr:impact>Multi-disciplinary research, Chemistry/pharmacology/clinical medicine. Two publications.
ChemMedChem. 2011 Jun 6;6(6):1017-23.
ChemMedChem. 2010 Aug 2;5(8):1247-53</gtr:impact><gtr:outcomeId>pzGe2xsdDdG-1</gtr:outcomeId><gtr:partnerContribution>Access to screening of novel cardiovascular compounds</gtr:partnerContribution><gtr:piContribution>Chemistry synthesis of compounds for testing</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Toronto</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Analysis of heart health data</gtr:description><gtr:id>CCA0CD88-6BDD-4244-B87F-83D0F3ABB115</gtr:id><gtr:impact>Six Months Funding from Unilever for data analysis on the work done to date in collaboration with Dr. Mike Gatt in Unilever Colworth and Prof. Rob Nolan in Toronto. This allowed additional use of the statistical complexity measures we have developed.</gtr:impact><gtr:outcomeId>hJZgLhgKVhw-1</gtr:outcomeId><gtr:partnerContribution>exchange of data</gtr:partnerContribution><gtr:piContribution>The project also stimulated additional research (which is ongoing) with Unilever on analysis of heart health data in collaboratidn with Prof. Robert Nolan from the University of Torronto in Canada.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>This is software for ECG analysis for use in the prediction of unusual heart rythms</gtr:description><gtr:id>B1A932B4-54DD-42F8-8088-E8C39E09769B</gtr:id><gtr:impact>This software is used in three institutions as part of further research into ECG analysis (Johns Hopkins, University of Moscow and Cambridge University)</gtr:impact><gtr:outcomeId>BC2zDvYGUsN</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>automatic QT detector</gtr:title><gtr:type>Model of mechanisms or symptoms - human</gtr:type><gtr:yearFirstProvided>2006</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>98491476-C9F3-4D7A-9260-C530859975FD</gtr:id><gtr:title>Complexity and spectral analysis of the heart rate variability dynamics for distant prediction of paroxysmal atrial fibrillation with artificial intelligence methods.</gtr:title><gtr:parentPublicationTitle>Artificial intelligence in medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5d7a79e271f36372dfcd20b52dd9c2df"><gtr:id>5d7a79e271f36372dfcd20b52dd9c2df</gtr:id><gtr:otherNames>Chesnokov YV</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0933-3657</gtr:issn><gtr:outcomeId>WBfGkZQdcVf</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0401505</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>89AE580F-2437-4540-9640-37005C968E67</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>4.1  Discovery and preclinical testing of markers and technologies</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>